BRAF V600-mutated Lung Carcinoma Treated With the Combination of Dabrafenib-trametinib: a Retrospective Evaluation
NCT04775095
·
clinicaltrials.gov ↗
COMPLETED
Status
163
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
BRAF V600 Mutation
Sponsor
Intergroupe Francophone de Cancerologie Thoracique
Collaborators
[object Object]